GRI Bio, Inc.
GRI
$1.98
$0.031.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.09% | -20.90% | 26.68% | 37.05% | 37.88% |
| Total Depreciation and Amortization | -185.71% | -2,600.00% | -1,150.00% | -2,600.00% | -163.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 904.17% | 506.82% | 27.46% | -25.10% | -116.67% |
| Change in Net Operating Assets | 132.39% | 115.02% | 7.10% | -126.67% | -162.81% |
| Cash from Operations | 24.30% | 18.24% | 23.27% | 4.22% | -184.79% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -13.49% | -10.65% | -52.91% | 13.07% | -6.31% |
| Repurchase of Common Stock | 0.00% | -- | -- | -- | 99.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -172.77% | -160.89% | 70.68% | 24.98% | 128.94% |
| Cash from Financing | -36.54% | -37.83% | -48.54% | 9.58% | 75.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.93% | -179.21% | -122.31% | 78.99% | -62.83% |